CD4+ (%) | CD4 + CD25+ (%) | CD8+ (%) | CD8 + CD25+ (%) | CD4/CD8 | VZV DNA (copies/mL) | ||
---|---|---|---|---|---|---|---|
Patient 1 | Acute Phase | 31 | 19 | 63 | 0.9 | 0.5 | 1.06E+ 07 |
1w after treatment | 41 | 14 | 51 | 0.4 | 0.8 | 3.72E+ 06 | |
2w after treatment | 20 | 11 | 46 | 0.1 | 1.1 | 1.64E+ 06 | |
Patient 3 | Acute Phase | 52 | 13 | 41 | 3.7 | 1.3 | 1.10E+ 06 |
1w after treatment | 61 | 16 | 33 | 1.2 | 1.8 | 1.65E+ 05 | |
2w after treatment | 61 | 19 | 32 | 2.0 | 1.9 | 6.14E+ 05 |